Low-dose apatinib optimizes tumor microenvironment and potentiates antitumor effect of PD-1/PD-L1 blockade in lung cancer-Reference-Cited by-同舟云学术

Low-dose apatinib optimizes tumor microenvironment and potentiates antitumor effect of PD-1/PD-L1 blockade in lung cancer

Published:2019-02-12 Issue: Volume: Page:canimm.0640.2017
ISSN:2326-6066
Container-title:Cancer Immunology Research
language:en
Short-container-title:Cancer Immunol Res

Author:

Zhao Sha,Ren Shengxiang,Jiang Tao,Zhu Bo,Li Xuefei,Zhao Chao,jia Yijun,Shi Jinpeng,zhang Limin,liu Xiaozhen,qiao Meng,Chen Xiaoxia,Su Chunxia,Yu Hui,Zhou Caicun,Zhang Jun^ORCID,Camidge D. Ross,Hirsch Fred R.

Funder

National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC)

National Key Research and Development Projects of Ch

IASLC Fellowship awards

The University of Iowa Start-up Funds

American Cancer SocietyAmerican Cancer Society (ACS)

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Immunology

Cited by 250 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment options for tumor progression after initial immunotherapy in advanced non-small cell lung cancer: A real-world study;Neoplasia;2024-11

2. Novel insights into immune cells modulation of tumor resistance;Critical Reviews in Oncology/Hematology;2024-10

3. A narrative review on advances in neoadjuvant immunotherapy for esophageal cancer: Molecular biomarkers and future directions;International Journal of Cancer;2024-09-14

4. Hepatic arterial-infusion chemotherapy combined with systemic therapy sequentially or simultaneously for advanced hepatocellular carcinoma;2024-09-09

5. Low Dosage of Apatinib as Salvage Treatment in Metastatic Lung Cancer With Clear Cell Renal Cell Carcinoma;American Journal of Therapeutics;2024-09